Lung Diseases They Didn’t Teach You About in Medical School

OSUWexnerbloglogo2014 Lung Diseases They Didn’t Teach You About in Medical School. On this CME webcast, we’re going to talk about 10 lung diseases that you probably didn’t learn about in medical school, either because they weren’t discovered at the time, we didn’t have good tests for at the time, or their importance wasn’t known about at the time.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: DIAGNOSE and treat
recently discovered genetic lung diseases; and DIAGNOSE and treat uncommon pulmonary infections.

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Learn About Peripheral Arterial Disease on CME Webcast

OSUWexnerbloglogo2014 Learn About Peripheral Arterial Disease on CME Webcast. On this on-line program, we are going to update you about new developments in peripheral artery disease. I’m pleased to introduce our guests. Dr. Michael Go is an Associate Professor of Surgery from the Division of Vascular Surgery here at Ohio State. And Dr. Said Atway is an Assistant Professor of Orthopedics from the Division of Podiatry.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: Review the anatomy and pathophysiology of PAD; and Review the demographics and diagnosis of PAD.

You’ll also learn about the following:

  • Limb preservation programs
  • Presenting signs and symptoms of foot ischemia
  • Tests used in evaluation of suspected peripheral arterial disease
  • Hyperbaric oxygen

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Learn About Medical Communication and Conflict Management

OSUWexnerbloglogo2014 Learn About Medical Communication and Conflict Management. On this CME webcast, we are going to show you how physicians can better communicate in order to improve patient care while avoiding hostility and burnout. Joining me in the studio is Assistant Professor of Internal Medicine, Dr. Shawn Corcoran.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: DESCRIBE the elements of the format for an effective consult; and DESCRIBE the components of self-regulation and detail what each of these components involve for you personally.

You’ll also learn about the following:

  • Things that go wrong during physician communication
  • The effect of electronic medical records on physician communication
  • Pros, cons, & etiquette: Pagers
  • Pros, cons, & etiquette: Text messaging
  • Pros, cons, & etiquette: Calling to a cell phone
  • Pros, cons, & etiquette: EMR messaging apps
  • How to avoid using 50 words for a 5 word sentence
  • Unique challenges of communication for insurance company denial appeals and prior authorizations

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Learn About New Therapies for Type 2 Diabetes

OSUWexnerbloglogo2014 Learn About New Therapies for Type 2 Diabetes. 25 years ago, the management of type II diabetes was easy. You started a patient on a sulfonylurea and then if their glucose level didn’t improve, you added in NPH insulin. But things have changed. And today, we have better and safer medications to treat diabetes. Which is a good thing because the prevalence of diabetes over the past 25 years has grown enormously and we really needed new treatments to fight against this public health threat. But with new treatments can come confusion about which to use in different clinical situations. Joining our moderator on this CME webcast, to update us on the management of type 2 diabetes is endocrinologist and Assistant Professor of Internal Medicine from the Ohio State University, Dr. Joshua Joseph.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: DESCRIBE the role of new medical therapies in hypoglycemia; and DESCRIBE the role of new medical therapies in cardiovascular disease.

You’ll also learn about the following:

  • New directions in the treatment of type 2 diabetes
  • Hemoglobin A1C targets
  • Treatment of type 2 diabetes when medication cost is a consideration
  • New glucose monitoring technologies

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Learn About Advances in Liver Disease on CME Webcast

OSUWexnerbloglogo2014 Learn About Advances in Liver Disease on CME Webcast. On this CME webcast, we’re going to hear about the latest chapter in the hepatitis C saga, that is, the treatment of hepatitis C. And we’re also going to hear about some of the other emerging liver diseases that you are likely to encounter in your clinical practice and some of the tools hepatologists use to evaluate liver conditions. Let me welcome today’s guests, both hepatologists from the Ohio State University. Dr. James Hanje is an Associate Professor of Internal Medicine and Dr. Anthony Michaels is also an Associate Professor of Internal Medicine.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: Recognize the change in patient population in patients with chronic liver disease; Describe the problem of frailty; Review
methods of Hepatitis C diagnosis and staging; and Review current therapeutic Hepatitis C treatment options.

You’ll also learn about the following:

  • Causes of liver disease in the United States
  • Hepatitis C
  • The economics of treating hepatitis C
  • Transmission of hepatitis C

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.